US stock market crash deepened Thursday as AI overhype fears collided with bleak jobs data. Dow Jones fell 0.8%, S&P 500 ...

Moderna beats Q3 forecasts as cost-cutting offsets weaker COVID vaccine sales and new mRNA cancer trials advance.

U.S. stock index futures rose slightly as investors analyzed corporate earnings amidst economic uncertainties. Positive ...

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand ...

Moderna’s third-quarter results weren’t as bad as they could have been, which was enough to trigger a rally in the stock on ...

Dow Jones Top Company Headlines at 11 AM ET: Warner Discovery Moving Fast on Split or Sale, CEO Says | Charles ... Chief Executive David Zaslav said the company's exploration of a possible sale of ...

Moderna Inc. continues to push its cost-savings work as Covid-19 vaccination rates decline. The company's third-quarter 2025 ...

Most tech stocks declined as worries over stretched valuations lingered, after a brief respite on Wednesday. Warnings of a market pullback from Wall Street executives on Tuesday had prompted a sharp ...

Mixed earnings results were being mentioned on Thursday as possible catalysts behind Thursday's stock-market action. Shares of Moderna Inc. were up more than 3% after the vaccine maker reported a ...

Investing.com-- U.S. stocks drifted in narrow trading ranges Thursday, with investors digesting more corporate earnings as ...

Wall Street trades cautiously as AI stock valuations, Fed outlook, and tariff hearings shape market sentiment on Thursday.